CD13 inhibitor effects on AML cell-lines
CD13 inhibitor effects on acute monocytic leukemia cell-lines (THP-1). We also compare the combination with proteasome inhibitors (Bortezomib). The experiment compared the effects of inhibiting CD13, with and without Bortezomib.